2022
Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter?
Rhee TG, Rosenheck RA. Admissions to substance use treatment facilities for cannabis use disorder, 2000–2017: Does legalization matter? American Journal On Addictions 2022, 31: 423-432. PMID: 35368113, DOI: 10.1111/ajad.13286.Peer-Reviewed Original Research
2019
Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users
Lazorwitz A, Aquilante C, Sheeder J, Guiahi M, Teal S. Relationship between patient characteristics and serum etonogestrel concentrations in contraceptive implant users. Contraception 2019, 100: 37-41. PMID: 30980827, PMCID: PMC6589369, DOI: 10.1016/j.contraception.2019.03.045.Peer-Reviewed Original ResearchConceptsSerum etonogestrel concentrationsContraceptive implant usersBody mass indexBlack/African American raceEtonogestrel concentrationsAfrican American raceMass indexPatient characteristicsImplant useEtonogestrel levelsImplant usersAmerican raceHispanic/Latina ethnicityMedian body mass indexSerum etonogestrel levelsEtonogestrel contraceptive implantSide effect profileReproductive-age womenCertain patient characteristicsIndividual patient characteristicsMajority of womenNon-significant increaseLatina ethnicityMedian ageSerum concentrationsGeneric and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016
Ross JS, Rohde S, Sangaralingham L, Brito JP, Choi L, Dutcher SK, Graham DJ, Jenkins MR, Lipska KJ, Mendoza M, Qiang Y, Wang Z, Wu Y, Yao X, Shah ND. Generic and Brand-Name Thyroid Hormone Drug Use Among Commercially Insured and Medicare Beneficiaries, 2007 Through 2016. The Journal Of Clinical Endocrinology & Metabolism 2019, 104: 2305-2314. PMID: 30690529, DOI: 10.1210/jc.2018-02197.Peer-Reviewed Original ResearchConceptsBrand-name useDrug useMedicare AdvantageThyroid hormone replacement therapyLarge administrative claims databaseBeneficiary populationAdministrative claims databaseHormone replacement therapyCertain patient characteristicsMedicare Part DPrescriber specialtyPatient characteristicsPrescriber characteristicsClaims databaseReplacement therapyGeneric levothyroxineWhite raceHealth plansOlder adultsHormone drugsInsurance coverageProduct useLevothyroxineNational dataPart D
2018
Evaluation of a score for the prehospital distinction between cerebrovascular disease and stroke mimic patients
Geisler F, Ali S, Ebinger M, Kunz A, Rozanski M, Waldschmidt C, Weber J, Wendt M, Winter B, Schwamm L, Audebert H. Evaluation of a score for the prehospital distinction between cerebrovascular disease and stroke mimic patients. International Journal Of Stroke 2018, 14: 400-408. PMID: 30303808, DOI: 10.1177/1747493018806194.Peer-Reviewed Original ResearchConceptsStroke mimic patientsIndividual patient characteristicsMimic patientsCerebrovascular diseaseStroke mimicsPatient characteristicsFocal neurological deficitsCerebrovascular disease patientsCertain patient characteristicsMobile stroke unitPre-hospital settingSevere strokeArterial hypertensionNeurological deficitsStroke unitAtrial fibrillationDisease patientsSudden onsetEmergency physiciansHospital destinationPatientsDiscriminative valueFinal analysisDiseaseStroke
2015
Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort
Turitz A, Bastek J, Purisch S, Elovitz M, Levine L. Patient characteristics associated with 17-alpha hydroxyprogesterone caproate use among a high-risk cohort. American Journal Of Obstetrics And Gynecology 2015, 214: 536.e1-536.e5. PMID: 26519784, PMCID: PMC4808591, DOI: 10.1016/j.ajog.2015.10.148.Peer-Reviewed Original ResearchConceptsPrior preterm birthPreterm birthFull-term birthSpontaneous PTBObstetrical historyPatient characteristicsPrior spontaneous preterm birthShort cervical lengthRecurrent preterm birthSpontaneous preterm birthPatient-level barriersSecond trimester lossHigh-risk cohortMultivariable logistic regressionCertain patient characteristicsStandard of careCohort of womenCross-sectional studySPTB rateCervical lengthNeonatal morbiditySingleton pregnanciesObstetric historyInsurance statusHydroxyprogesterone caproate
This site is protected by hCaptcha and its Privacy Policy and Terms of Service apply